Biopool International to Trade on OTC Bulletin Board.VENTURA, Calif.--(BUSINESS WIRE)--April 19, 1999-- Biopool International Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:BIPL BIPL Biphase Level ) Monday announced that effective this date, its shares will no longer trade on the Nasdaq's SmallCap Market because the bid price for its shares has fallen below the $1-per-share Nasdaq minimum listing maintenance requirement. The company's stock now immediately qualifies to trade on the OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. under the symbol BIPL. Michael D. Bick, Ph.D., chairman and chief executive officer of Biopool, commented: "The move to the OTC Bulletin Board in no way reflects any adverse financial conditions within the company. Indeed, we meet and exceed all listing requirements Listing requirements Requirements, including minimum shares outstanding, market value, and income, that are laid down by an exchange for any stock to be listed for trading. for Nasdaq other than the $1 minimum bid price." Founded in 1987, Biopool International develops, manufactures and markets a full range of test kits to assess and diagnose disorders of blood coagulation, thrombotic risk factors, fibrinolysis fibrinolysis /fi·bri·nol·y·sis/ (fi?brin-ol´i-sis) dissolution of fibrin by enzymatic action.fibrinolyt´ic fi·bri·nol·y·sis n. pl. , platelet function and the vascular system, and specialty chemistry controls used to monitor and measure the presence of drugs of abuse. The company's product line is sold to hospitals, clinical laboratories, commercial reference laboratories and research institutions on a worldwide basis by the company's own sales representatives, as well as through an extensive network of distributors. To learn more about Biopool, visit the company's Web site at http://www.biopool.com. This news release contains forward-looking statements that are based upon current expectations that involve a number of risks and uncertainties, including but not limited to technological innovations of competitors, changes in health-care regulations, litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. claims, foreign-currency fluctuation, product acceptance or changes in government regulation of the company's products, as well as other factors discussed in the company's last report on Form 10-K-SB under "Risk Factors." |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion